The vaccine, known as CoronaVac, is still in phase 3 clinical trials in Brazil and has not been registered for wider use in Brazil, Anvisa said.
Brazil health auth. OKs import of 6 mln doses of Chinese COVID-19 vaccine
By REUTERS
09/09/2024 04:42 AM
By REUTERS
09/08/2024 11:18 PM
By REUTERS
09/08/2024 10:17 PM
By REUTERS
09/08/2024 06:27 PM
By REUTERS
09/08/2024 05:45 PM
By REUTERS
09/08/2024 09:17 AM